4-(2-Chloro-9-methyl-9H-purin-6-yl)morpholine, 95.0%, 100mg

(5Z)-5-(3-ethoxy-2-hydroxybenzylidene)-3-methyl-2-thioxo-1,3-thiazolidin-4-one, 95.0%, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoic acid, 97%, 25g

5-Bromo-2-(trifluoromethyl)isonicotinonitrile, 97%, 250mg

8-Chloro-[1,2,4]triazolo[1,5-a]pyridine, 98%, 10g

(R)-2-(Methylamino)-3-phenylpropanoic acid, 95.0%, 25g

2-Propanol, min. 99.5%, for synthesis, 5 l, plastic packaging.

Accessories exchange block for reaction vessels, Gesch. for, 24 reaction vials 0.5 and 1.5 ml (combi block), 1 piece

2,3-Diamino-5-chloropyridine, 98.0%, 5g

(Tetrahydrofuran-2,5-diyl)dimethanol (mixture of isomers)>98.0%(GC)1g

Cyclamic acid (sodium), 1kg

4-[(2-Methoxyphenyl)methyl]oxan-4-amine, 1g

cis-3-Aminocyclobutanol hydrochloride, 95.0%, 10g